Prudential Financial
DNLI icon

Prudential Financial’s Denali Therapeutics DNLI Stock Holding History

Prudential Financial’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
58,135
+27,565
+90% +$566K ﹤0.01% 1504
2026
Q1 		$587K Buy
+30,570
New +$608K ﹤0.01% 1801
2025
Q4 		– Sell
-16,938
Closed -$246K – 2274
2025
Q3 		$246K Buy
16,938
+60
+0.4% +$862 ﹤0.01% 2161
2025
Q2 		$236K Sell
16,878
-21,765
-56% -$306K ﹤0.01% 2163
2025
Q1 		$525K Sell
38,643
-71,950
-65% -$1.38M ﹤0.01% 1820
2024
Q4 		$2.25M Sell
110,593
-6,800
-6% -$174K ﹤0.01% 1245
2024
Q3 		$3.42M Buy
117,393
+650
+0.6% +$16.1K ﹤0.01% 1180
2024
Q2 		$2.71M Buy
116,743
+36,314
+45% +$697K ﹤0.01% 1241
2024
Q1 		$1.65M Sell
80,429
-815
-1% -$15.3K ﹤0.01% 1557
2023
Q4 		$1.74M Sell
81,244
-72,584
-47% -$1.44M ﹤0.01% 1521
2023
Q3 		$3.17M Buy
153,828
+29,506
+24% +$748K 0.01% 1113
2023
Q2 		$3.67M Buy
124,322
+115,142
+1,254% +$3.24M 0.01% 1056
2023
Q1 		$287K Sell
9,180
-6
-0.1% -$165 ﹤0.01% 2279
2022
Q4 		$255K Buy
9,186
+897
+11% +$26.7K ﹤0.01% 2319
2022
Q3 		$243K Buy
8,289
+54
+0.7% +$1.76K ﹤0.01% 2395
2022
Q2 		$238K Sell
8,235
-12,518
-60% -$328K ﹤0.01% 2417
2022
Q1 		$667K Sell
20,753
-195,048
-90% -$6.71M ﹤0.01% 2066
2021
Q4 		$9.71M Buy
215,801
+28,339
+15% +$1.34M 0.01% 736
2021
Q3 		$9.46M Sell
187,462
-32,552
-15% -$1.83M 0.01% 753
2021
Q2 		$17.3M Buy
220,014
+32,070
+17% +$1.98M 0.02% 570
2021
Q1 		$10.7M Buy
187,944
+98,225
+109% +$6.58M 0.02% 737
2020
Q4 		$7.51M Buy
89,719
+55,914
+165% +$3.38M 0.01% 852
2020
Q3 		$1.21M Buy
+33,805
New +$1.02M ﹤0.01% 1550

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial's DNLI Position: Q2 2026 in Review

Prudential Financial increased its Denali Therapeutics (DNLI) stake by 90% in Q2 2026, buying an estimated $566K and bringing the position to 58,135 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Prudential Financial first reported a position in DNLI in Q3 2020 and has held it in 23 quarters since. The position peaked at $17.3M in Q2 2021. 212 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Prudential Financial held 58,135 shares of Denali Therapeutics worth $1.5M as of Q2 2026.
  • Prudential Financial bought 27,565 Denali Therapeutics shares in Q2 2026, an estimated $566K.
  • Denali Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1504 holding.
  • Prudential Financial first reported a position in Denali Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Prudential Financial's Denali Therapeutics position peaked at $17.3M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.